Skip to main content
ATRC logo

ATRC

AtriCure, Inc.
$34.28 -0.28 (-0.81%) At close · Jul 10
Market Cap
$1.74B
Shares
50,640,970

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$534.53M +14.9%
FY2025 Revenue FY2011–FY2025
Net Income
-$11.45M +74.4%
FY2025 Net Income FY2011–FY2025
Gross Margin
74.98% +0.3pp
FY2025 Gross Margin FY2011–FY2025
Operating Margin
-1.77% +6.8pp
FY2025 Operating Margin FY2011–FY2025
Diluted EPS
-$0.24 +74.7%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
$57.33M +369.8%
FY2025 Operating Cash Flow FY2011–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
$600M – $610M $552.16M $534.53M $465.31M $399.25M $330.38M $274.33M $206.53M $230.81M $201.63M $174.72M $155.11M $129.76M $107.45M $81.89M $70.25M $64.4M
$3.13M
$134.7M $133.75M $117.78M $98.88M $84.44M $68.47M $57.22M $60.47M $54.51M $48.55M $44.01M $36.88M $31.7M $22.33M $20.23M $17.41M
$417.46M $400.78M $347.52M $300.37M $245.94M $205.86M $149.31M $170.34M $147.12M $126.16M $111.1M $92.88M $75.75M $59.56M $50.01M $47M
74.98% 74.69% 75.23% 74.44% 75.04% 72.29% 73.8% 72.97% 72.21% 71.63% 71.58% 70.5% 72.74% 71.2% 72.97%
$100.92M $99.21M $96.18M $73.92M $57.34M $48.51M $43.07M $41.23M $34.72M $34.14M $35.82M $25.74M $18.6M $13.44M $12.15M $11.86M
$319.51M $311.02M $291.36M $253.14M $231.27M $204.65M $150.47M $162.23M $129.52M $117M $106.42M $93.85M $73.51M $57.01M $45.07M $39.87M
$8.72M $8.44M $7.52M $5.35M $3.65M $2.91M $1.68M $1.94M $1.51M $1.37M $1.64M $1.3M $1.42M $12K $13K $44.58K
$420.43M $410.23M $387.54M $327.05M $288.61M $150.66M $193.54M $203.46M $164.25M $151.14M $142.24M $119.6M $92.11M $70.45M $57.21M $51.73M
-$2.97M -$9.45M -$40.01M -$26.68M -$42.67M $55.21M -$44.23M -$33.12M -$17.13M -$24.98M -$31.14M -$26.72M -$16.36M $10.89M -$7.2M -$4.73M
-1.77% -8.6% -6.68% -12.92% 20.12% -21.42% -14.35% -8.49% -14.3% -20.07% -20.59% -15.23% 13.3% -10.25% -7.35%
$5.8M $5.88M $6.41M $6.93M $4.99M $4.92M $4.89M $4.11M $4.61M $2.26M $1.8M $292K $305K $566K $802K $814.43K
$4.68M $4.48M $4.43M $3.79M $1.99M $466K $1.1M $2.4M $1.01M $227K $227K $190K $96K $16K $11K $15.93K
$826K $683K -$326K -$31K -$537K -$366K -$24K -$160K -$183K $138K -$586K -$354K $391K -$3000 $505K $104.42K
$0 $0 $0 $0 $0 $0 $0
-$3.26M -$10.16M -$43.67M -$29.85M -$46.2M $50.39M -$48.04M -$35M -$20.91M -$26.88M -$33.3M -$27.18M -$16.18M -$11.44M -$7.48M -$5.42M
$1.33M $1.29M $1.02M $591K $268K $188K $114K $199K $226K $14K $40K $36K $33K $18K $50K $30.89K
-$4.59M -$11.45M -$44.7M -$30.44M -$46.47M $50.2M -$48.16M -$35.19M -$21.14M -$26.89M -$33.34M -$27.21M -$16.21M -$11.46M -$7.53M -$5.46M
-2.14% -9.61% -7.62% -14.06% 18.3% -23.32% -15.25% -10.48% -15.39% -21.49% -20.97% -15.09% -14% -10.73% -8.47%
-$4.14M -$9.85M -$44.74M -$27.34M -$49.61M $48.94M -$47.69M -$35.15M -$21.37M -$26.39M -$33.2M -$27.48M -$16.42M -$11.68M -$7.42M
USD/shares -$0.24 -$0.95 -$0.66 -$1.02 $1.11
USD/shares $0.00 – $0.04* -$0.24 -$0.95 -$0.66 -$1.02 $1.09
shares 47.75M 46.97M 46.31M 45.74M 45.07M 42.13M 37.59M 34.09M 32.39M 31.61M 28.06M 26.37M 20.43M 16.19M
shares 47.75M 46.97M 46.31M 45.74M 46.04M 42.13M 37.59M 34.09M 32.39M 31.61M 28.06M 26.37M 20.43M 16.19M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Medical Instruments & Supplies median 1.82×
EV/EBIT
Medical Instruments & Supplies median 32.36×
P/E (TTM)
Medical Instruments & Supplies median 37.77×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
United States $435,372,000 $382,816,000 $333,544,000 $277,201,000 $229,131,000 $169,244,000 $185,829,000 $162,146,000
Non Us $99,156,000 $82,491,000 $65,701,000 $53,178,000 $45,198,000 $37,287,000 $44,978,000 $39,484,000
Europe $61,493,000 $49,874,000 $38,469,000 $30,428,000 $27,931,000 $23,217,000 $27,929,000 $25,912,000
Asia Pacific $30,723,000 $27,379,000 $24,526,000 $20,734,000 $16,077,000
Other International $6,940,000 $5,238,000 $2,706,000 $2,016,000 $1,190,000 $952,000 $1,073,000 $885,000
Asia $20,734,000 $16,077,000 $13,118,000 $15,976,000 $12,687,000

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Shipping And Handling $2,451,000 $2,421,000 $1,860,000 $1,496,000 $1,354,000 $1,192,000 $1,485,000 $1,236,000
Key facts CIK 1323885 CUSIP 04963C209 13F (30d) 7 filings 7 filers Visit website Investor relations